Acupuncture for Functional Constipation in Older Adults : A Randomized Controlled Clinical Trial

Sponsor
Shanghai University of Traditional Chinese Medicine (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05496543
Collaborator
Shanghai Municipal Hospital of Traditional Chinese Medicine (Other), Longhua Hospital (Other)
84
1
2
24
3.5

Study Details

Study Description

Brief Summary

Through a scientific and standardized randomized controlled study, we observe the effectiveness and safety of acupuncture in the treatment of functional constipation in the elderly through the method of "nourishing kidney and dredging Fu organs".

Condition or Disease Intervention/Treatment Phase
  • Device: acupuncture
  • Device: sham acupuncture
N/A

Detailed Description

Functional constipation is a common disease of old people. To date, there has not specific therapy on it. Former research showed acupuncture may work for functional constipation. In the trial, patients in the acupuncture and sham acupuncture groups will receive 24 acupuncture treatments over an 8-week period. This RCT is designed to confirm the efficacy and safety of acupuncture in functional constipation treatment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
84 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Randomized Controlled Clinical Trial of Acupuncture in Nourishing Kidney and Dredging Fu Organs for Functional Constipation in Older Adults
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2024
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Acupuncture group

Participants will receive acupuncture treatment at Zhao Hai(KI 6), Da Zhong(KI 4), Tai Xi(KI 3), Tian Shu(ST 25), and Shang Ju Xu(ST 37) bilaterally. Each treatment will last 30 minutes and participants will receive the treatment 3 times per week (every other day) for 8 weeks, 24 sessions in total. Follow-up time is week 4 and week 12 after treatment (ie, week 12 and week 20).

Device: acupuncture
All acupoints will be routinely sterilized at first. After the insertion of the needles, manipulations of lifting, twirling, and thrusting are performed on all needles to reach de qi, which is a sensation typically associated with needling including soreness, numbness, swelling, heaviness, and other feelings. This is considered to be an important component of the therapeutic effect of acupuncture.

Placebo Comparator: Sham acupuncture group

Participants will receive sham acupuncture treatment on bilateral sham Zhao Hai(KI 6), Da Zhong(KI 4), Tai Xi(KI 3), Tian Shu(ST 25), and Shang Ju Xu(ST 37) that match real acupuncture points. The duration of needle retention, treatment period, and follow-up in the control group is the same as that in the intervention group.

Device: sham acupuncture
The placebo needles chosen for this study are flat-tipped needles without a tip, which could not be pierced into the skin. In the meanwhile, an external patch device will fix the needles, which are visually pierced into the skin. After the treatment, the acupuncturist will press the acupuncture point with a dry cotton ball so that the patient can feel the pulling out of the "needle".

Outcome Measures

Primary Outcome Measures

  1. The change in the mean number of CSBMs per week compared to baseline during the 8-week treatment period [At baseline, week 4 (in treatment), week 8 (end of treatment), and the follow-up period (week 12 and week 20 after randomization).]

    Complete Spontaneous Bowel Movements (CSBMs) refers to the frequency of a bowel movement that occurred in the absence of laxatives or manipulation.

Secondary Outcome Measures

  1. Bristol Stool Scale [At baseline and at week 8 (end of treatment).]

    A scale to classify the patient's voluntary bowel movement stool.

  2. Patient Assessment of Constipation-Symptoms (PAC-SYM) [At baseline and at week 8 (end of treatment).]

    A scale to assess the condition of the patient's constipation-related symptoms

  3. Patient Assessment of Constipation Quality of Life Questionnaire (PAC-QOL) [At baseline and at week 8 (end of treatment).]

    A brief but comprehensive assessment of the daily life quality of patients with FC, containing 28 items

  4. Self-rating Anxiety Scale(SAS) [At baseline and at week 8 (end of treatment).]

    A measure of somatic symptoms associated with anxiety reactions.

  5. Self-rating Depression Scale(SDS) [At baseline and at week 8 (end of treatment).]

    A self-rating scale to assess patients' depression

  6. Weekly usage of emergency bowel medications [At baseline and at week 8 (end of treatment).]

    The proportions of participants using medications and doses for emergency treatment

  7. Incidence of adverse events [During 1-8 weeks]

    The adverse events (AEs) assessment aims at evaluating the AEs of acupuncture treatment.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Meet Rome IV Diagnostic Criteria for Constipation and TCM Diagnostic Criteria of constipation with yin deficiency syndrome;

  • No gender restriction, age 60-80;

  • FC that is classified as mild or moderate;

  • Have not used any medicine for constipation at least 2 weeks before treatment (except emergency treatment);

  • Have not participated in other medical clinical trials over the past one month;

  • Those who can understand various evaluation scales, complete the evaluation and cooperate with the completion of the planned course of treatment;

  • Sign the informed consent.

Exclusion Criteria:
  • Irritable bowel syndrome and constipation caused by tumors, inflammatory reactions, endocrine and metabolic diseases, and drugs;

  • Constipation caused by organic diseases;

  • Patients with serious primary diseases such as heart, brain, liver, kidney and hematopoietic system, infectious diseases, tumors, and mental diseases;

  • Those who voluntarily give up or cannot cooperate with treatment and observation due to various circumstances;

  • Patients with cognitive impairment or aphasia;

  • Those who take other drugs during treatment, which affect the efficacy and judgment (except emergency treatment).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Longhua Hospital Shanghai China 200032

Sponsors and Collaborators

  • Shanghai University of Traditional Chinese Medicine
  • Shanghai Municipal Hospital of Traditional Chinese Medicine
  • Longhua Hospital

Investigators

  • Principal Investigator: PING YIN, Shanghai University of Traditional Chinese Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Shanghai University of Traditional Chinese Medicine
ClinicalTrials.gov Identifier:
NCT05496543
Other Study ID Numbers:
  • 21Y11923900
First Posted:
Aug 11, 2022
Last Update Posted:
Aug 11, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 11, 2022